Item 9 Labs Stock Analysis

INLB Stock  USD 0.0001  0.00  0.00%   
Item 9 Labs is overvalued with Real Value of 6.3E-5 and Hype Value of 1.0E-4. The main objective of Item 9 pink sheet analysis is to determine its intrinsic value, which is an estimate of what Item 9 Labs is worth, separate from its market price. There are two main types of Item 9's stock analysis: fundamental analysis and technical analysis.
The Item 9 pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Item 9's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Item 9 Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Item Pink Sheet Analysis Notes

About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Item 9 Labs recorded a loss per share of 0.18. The entity last dividend was issued on the 18th of October 2018. The firm had 1:20 split on the 18th of October 2018. Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people.The quote for Item 9 Labs is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Item 9 Labs call Andrew Bowden at 833 867 6337 or check out https://www.item9labscorp.com.

Item 9 Labs Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Item 9's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Item 9 Labs or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Item 9 Labs is way too risky over 90 days horizon
Item 9 Labs has some characteristics of a very speculative penny stock
Item 9 Labs appears to be risky and price may revert if volatility continues
Item 9 Labs currently holds 7.22 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Item 9 Labs has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Item 9 until it has trouble settling it off, either with new capital or with free cash flow. So, Item 9's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Item 9 Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Item to invest in growth at high rates of return. When we think about Item 9's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 21.76 M. Net Loss for the year was (31.14 M) with profit before overhead, payroll, taxes, and interest of 7.31 M.
Item 9 Labs currently holds about 441.66 K in cash with (2.25 M) of positive cash flow from operations.
Roughly 26.0% of Item 9 shares are held by company insiders

Item Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Item 9's market, we take the total number of its shares issued and multiply it by Item 9's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Item Profitablity

The company has Profit Margin (PM) of (1.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6.

Technical Drivers

Item 9 technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Item 9 Labs Price Movement Analysis

java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Item 9 middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Item 9 Labs. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Item 9 Outstanding Bonds

Item 9 issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Item 9 Labs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Item bonds can be classified according to their maturity, which is the date when Item 9 Labs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

About Item Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Item 9 prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Item shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Item 9. By using and applying Item Pink Sheet analysis, traders can create a robust methodology for identifying Item entry and exit points for their positions.
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Item 9 to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run AI Portfolio Architect Now

   

AI Portfolio Architect

Use AI to generate optimal portfolios and find profitable investment opportunities
All  Next Launch Module

Complementary Tools for Item Pink Sheet analysis

When running Item 9's price analysis, check to measure Item 9's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Item 9 is operating at the current time. Most of Item 9's value examination focuses on studying past and present price action to predict the probability of Item 9's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Item 9's price. Additionally, you may evaluate how the addition of Item 9 to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years